Technology | Thrombectomy Devices | July 25, 2019

Penumbra Launches Jet 7 Reperfusion Catheter With Xtra Flex Technology in U.S.

Catheter is used with Penumbra Engine in fully integrated Penumbra System for aspiration-based mechanical thrombectomy

Penumbra Launches Jet 7 Reperfusion Catheter With Xtra Flex Technology in U.S.

July 25, 2019 — Penumbra announced U.S. commercial availability of the Penumbra System’s most advanced technology, the Penumbra Jet 7 Reperfusion Catheter with Xtra Flex technology, at the Society of NeuroInterventional Surgery (SNIS) 16th Annual Meeting, July 22-25 in Miami. Penumbra Jet 7 with Xtra Flex technology is used with the Penumbra Engine in the fully integrated Penumbra System – an aspiration-based mechanical thrombectomy system that enables physicians to extract thrombus in acute ischemic stroke patients.

The Penumbra System is a fully integrated system designed specifically for mechanical thrombectomy by aspiration that first received 510(k) clearance by the U.S. Food & Drug Administration (FDA) in December 2007. It enables physicians to use aspiration, which acts like a minimally invasive “vacuum” inside the artery to remove stroke-causing blood clots from the brain safely and effectively. It is intended for use in the revascularization of patients with acute ischemic stroke secondary to intracranial large vessel occlusion.

The Penumbra Jet 7 Reperfusion Catheter with Xtra Flex technology is the latest advancement in the Penumbra System Jet – Engine family of products, which was launched last September.  As the eighth-generation reperfusion catheter for proximal large vessel occlusions, the catheter is designed for advanced trackability and navigation, and maintains the large 0.072-inch lumen.  Penumbra Jet 7 with Xtra Flex technology together with the power of the Penumbra Engine are designed to maximize thrombus removal force.

Initial clinical experience with the new technology was shared in the Industry Technology Luncheon Symposium by Donald F. Frei, M.D., director of neuro-interventional surgery, Swedish Medical Center, Englewood, Colo. 

For more information: www.penumbrainc.com

Related Content

Sponsored Content | Videos | Cath Lab

Advancements in analytics and data visualizations are helping to streamline operations and improve productivity at cath ...

Home January 13, 2022
Home
News | Cath Lab

January 4, 2022 — The U.S. Food and Drug Administration (FDA) has authorized marketing of the first laser-based device ...

Home January 04, 2022
Home
News | Cath Lab

December 14, 2021 — RSIP Vision, a medical imaging company applying advanced artificial intelligence (AI) and computer ...

Home December 14, 2021
Home
Feature | Cath Lab

November 15, 2021 — RealView Imaging Ltd. recently received FDA 510(k) clearance for its Holoscope-i holographic system ...

Home November 15, 2021
Home
News | Cath Lab

November 10, 2021 — Shockwave Medical a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely ...

Home November 10, 2021
Home
News | Cath Lab

November 10, 2021 — Philips Healthcare announced North American availability of new innovations in its portfolio of ...

Home November 10, 2021
Home
News | Cath Lab

October 6, 2021 — Boston Scientific Corp. announced it entered into a definitive agreement to acquire Baylis Medical ...

Home October 06, 2021
Home
News | Cath Lab

September 21, 2021 — Medtronic is recalling its Pipeline Flex Embolization Device and Pipeline Flex Embolization Device ...

Home September 21, 2021
Home
Feature | Cath Lab | By Aaron Detate and Lars Thording

In the electrophysiology (EP) lab, hundreds of thousands of used devices are sent to reprocessors every year to get ...

Home September 14, 2021
Home
News | Cath Lab

July 22, 2021 — Medis Medical Imaging is partnering with CORRIB Core Lab and Sinomed in randomized clinical trial of ...

Home July 22, 2021
Home
Subscribe Now